Close Menu

NEW YORK — Private equity firm GTCR said on Tuesday that its Cole-Parmer business has acquired ZeptoMetrix, a maker of quality control standards and verification panels used in infectious disease molecular diagnostic testing.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.